MAIA Biotechnology (MAIA) Exchange Rate Effect (2022 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Exchange Rate Effect of $14086.0 for Q1 2026, up 360.93% year-over-year from $3056.0 in Q1 2025, and up 190.26% quarter-over-quarter from -$15606.0 in Q4 2025.
MAIA Biotechnology (MAIA) Exchange Rate Effect (2022 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Exchange Rate Effect for 5 consecutive years, with $14086.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 360.93% year-over-year to $14086.0; the TTM figure through Mar 2026 stood at $5814.0 (up 164.64% YoY), while the FY2025 annual figure was -$5216.0, up 75.79% from the prior year.
- Exchange Rate Effect climbed to $14086.0 in Q1 2026 per MAIA's latest filing, from -$15606.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $29904.0 in Q4 2022 and bottomed at -$26258.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$1013.1 across 5 years, with a median of -$1169.0 in 2024.
- On a YoY basis, Exchange Rate Effect climbed as much as 469.6% in 2024 and fell as far as 224.4% in 2024.
- MAIA Biotechnology's Exchange Rate Effect stood at $29904.0 in 2022, then tumbled by 56.14% to $13116.0 in 2023, then sank by 224.4% to -$16316.0 in 2024, then climbed by 4.35% to -$15606.0 in 2025, then jumped by 190.26% to $14086.0 in 2026.
- Business Quant data shows MAIA's Exchange Rate Effect at $14086.0 in Q1 2026, -$15606.0 in Q4 2025, and -$1039.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | -2,224.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,224.00 |
| Jun 30, 2026 | -2,224.00 |
| Mar 31, 2026 | 14,086.00 |
| Mar 31, 2026 | 14,086.00 |
| Dec 31, 2025 | -15,606.00 |
| Dec 31, 2025 | -15,606.00 |
| Sep 30, 2025 | -1,039.00 |
| Sep 30, 2025 | -1,039.00 |
| Jun 30, 2025 | 8,373.00 |
| Jun 30, 2025 | 8,373.00 |
| Mar 31, 2025 | 3,056.00 |
| Mar 31, 2025 | 3,056.00 |
| Dec 31, 2024 | -16,316.00 |
| Dec 31, 2024 | -16,316.00 |
| Sep 30, 2024 | -1,169.00 |
| Sep 30, 2024 | -1,169.00 |
| Jun 30, 2024 | 5,434.00 |
| Jun 30, 2024 | 5,434.00 |
| Mar 31, 2024 | -9,494.00 |
| Mar 31, 2024 | -9,494.00 |